Linear Health Sciences Announces Publication of Device Profile for Orchid SRV™

Dec 31, 2023

Device Profile Published in the Journal Expert Review of Medical Devices Details Unmet Need Addressed by Novel IV Safety Release Valve Technology

OKLAHOMA CITY, June 06, 2023--(BUSINESS WIRE)--Medical device company Linear Health Sciences today announced the online publication of a device profile of its Orchid SRV™ tension-activated breakaway safety release valve in the peer-reviewed journal Expert Review of Medical Devices.

The profile, "Device profile of the Orchid safety release valve for the prevention of accidental catheter dislodgement," was authored by patient safety expert Nancy L. Moureau, RN, PhD, BSN, CRNI, CPUI, VA-BC, and provides an in-depth examination of the device's performance standards, safety and complications, contraindications, alternative devices, regulatory status, and a healthcare cost and value analysis.

More than 80 percent of patients in acute care require intravenous catheters, with complications of catheter dislodgement and failure commonly reported at rates of 15 to 69 percent, causing interrupted treatment and greater resource consumption when catheter replacement is required.

Orchid SRV is a sterile, single-use connector for needle-free access that is placed between the existing IV extension set and general IV tubing connection. When tension (of up to 3.25 lbs.) acts on the IV line, the valve separates and creates a sterile barrier on both sides of the IV. The clinician then restores the line simply by removing the separated halves and replacing them with a new, pre-packaged, sterile valve. The Orchid SRV is cleared for use in adult and pediatric patients in patients two weeks of age and older.

"Accidental dislodgement of vascular access devices, especially peripheral catheters, is a common occurrence that warrants increased awareness of the need for safety to protect patients from unnecessary catheter failure and associated complications," Moreau wrote in the profile. "By adding a simple accessory that attaches to the IV catheter and IV administration set, more than 88 percent of catheter dislodgement from pull force tension can be avoided."

Reports have shown that, of the 342 million peripheral IVs in the U.S. each year1, up to 10 percent may dislodge2, costing more than $2 billion annually3. Dislodgement is most frequently caused by patient confusion or removal of the catheter, loose dressing or tape, or tubing becoming tangled in bed linens.

"This publication underscores the impact that reducing catheter dislodgement can have on patient outcomes and healthcare's bottom line," said Dan Clark, co-founder and CEO of Linear Health Sciences. "This type of critical innovation within the vascular access space, and other medical tubing applications, is crucial to the advancement of the standard of care."

Linear Health Sciences won an Innovative Technology Award for Orchid SRV from Vizient, making the device available to hospital customers through a non-exclusive contract with the group purchasing organization (GPO). Additionally, the device is available nationwide and across Canada. Qualified clinical evaluations of Orchid SRV will continually quantify device utilization, driving Linear Health Science's next generations of innovation.

About Linear Health Sciences

Linear Health Sciences is a medical device company that has developed a proprietary, breakaway safety valve technology designed to improve the use of medical tubing in hospitals. The platform technology was developed to increase the safety and satisfaction of patients, caregivers, and healthcare facilities, while dramatically reducing costs. The company's initial products include the Orchid SRV for use in IV catheter therapy and the Orchid SRV Type D device for use in surgical/wound, nephrostomy and abscess drainage. For more information, visit linearsciences.com.

References:1 iData research report2 "The Peripheral Intravenous Catheter Journey: A Prospective Cohort Study of 1000 Patients." Podium presentation by Nicole Marsh, RN, and Claire Rickard, RN, PhD, AVA 2017 annual meeting3 Helm, et al. "Accepted but unacceptable: peripheral IV catheter failure" J Infus Nurs May-Jun 2015;38(3):189-203. doi: 10.1097/NAN.0000000000000100

View source version on businesswire.com: https://www.businesswire.com/news/home/20230606005494/en/

Contacts

Sam ChoinskiPazanga Health [email protected] (860) 301-5058